Jackie Heda

Cancer Therapy: TP-1454 MOA 

Prev Next
Previous

TP-3654

medical illustration of TP-1454 is an investigational oral pyruvate kinase (PKM2) activator. This activation is thought to starve the cells of important molecular building blocks, inhibiting tumor cell production, and enhancing anti-tumor response.
#cancer therapy #trimer #PKM2 activator #tumor cell #anti-tumor
Next medical illustration of Napabucasin is an investigational product that increases reactive oxygen species in an environment of proliferating cancer cells, causing cancer cell death.

#cancer therapy # cell signaling #ROS #cancer cell death #NQO1 #cancer cell survival #redox balance

Cancer Therapy: Napabucasin

TP-1454 is an investigational oral pyruvate kinase (PKM2) activator. This activation is thought to starve the cells of important molecular building blocks, inhibiting tumor cell production, and enhancing anti-tumor response. #cancer therapy #trimer #PKM2 activator #tumor cell #anti-tumor

Keywords: 3D, Patient Education, Professional Education, Oncology, Mechanism of Action (MOA), Health & Wellness

© Jackie Heda